RAPID: Developing a universal modular platform to engineer coronavirus vaccine candidates — NSF Award to University of Illinois at
With this award, the Chemistry of Life Processes program in the Chemistry Division supports the studies by Dr. Angad Mehta at the University of Illinois at Urbana-Champaign to make live attenuated forms of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that require an unnatural compound to reproduce.
| Award title | RAPID: Developing a universal modular platform to engineer coronavirus vaccine candidates |
|---|---|
| Award ID | 2037695 |
| Awardee | University of Illinois at Urbana-Champaign |
| City | URBANA |
| State | IL |
| Amount obligated | $200,000 |
| Principal investigator | Angad Mehta |
| Program | Chemistry of Life Processes |
| Start date | 07/15/2020 |
| Abstract | With this award, the Chemistry of Life Processes program in the Chemistry Division supports the studies by Dr. Angad Mehta at the University of Illinois at Urbana-Champaign to make live attenuated forms of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that require an unnatural compound to reproduce. SARS-CoV-2 is the virus that causes coronavirus disease 2019 (COVID-19). Live-attenuated viruses have reduced abilities to cause disease, but remain capable of providing immunity i |
| Source | NSF Awards |
$799/mo
Try NSFGrants →